FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2397956340> ?p ?o ?g. }

• W2397956340 endingPage "43712" @default.
• W2397956340 startingPage "43703" @default.
• W2397956340 abstract "// Zheng Wang 1, 2 , Xinghan Liu 1 , Xijing Wang 1 , Tie Chong 3 , Shuai Lin 1 , Meng Wang 1 , Xiaobin Ma 1 , Kang Liu 1 , Peng Xu 1 , Yanjing Feng 1 , Zhijun Dai 1 1 Department of Oncology, Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710004, China 2 Department of Medical Oncology, Xi’an Central Hospital, Xi’an 710004, China 3 Department of Urologic Surgery, Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710004, China Correspondence to: Zhijun Dai, email: dzj0911@126.com ; dzj0911@mail.xjtu.edu.cn Keywords: TIM-3, breast cancer, polymorphism, case-control study Received: December 22, 2015     Accepted: May 12, 2016     Published: May 27, 2016 ABSTRACT Previous studies have found associations between polymorphisms in T cell immunoglobulin and mucin domain 3 ( TIM-3 ) and increased risks of various cancers. However, the association between TIM-3 polymorphisms and breast cancer (BC) remains uncertain. In this study, a total of 560 BC patients and 583 age, sex, and ethnicity-matched healthy controls from Northwest China were included. The polymorphisms were genotyped using Sequenom MassARRAY. The expression level of TIM-3 protein was detected by immunohistochemistry. We observed rs10053538 had a significantly increased risk of BC, comparing with the wild-type genotype even after Bonferroni correction. In addition, the rs4704853 G>A variants were more frequent among BC patients than the controls (GA + AA vs. GG: OR = 1.32, 95% CI = 1.03-1.69, P = 0.026); However, the significance was lost after Bonferroni correction (P = 0.078). Furthermore, rs10053538 was associated with lymph node metastasis. Age stratification revealed that among patients aged <49 years, those with the rs4704853 GA/AA genotype had a higher risk of BC; But there was no difference when Bonferroni correction was conducted. Immunohistochemical analysis showed that the expression of TIM-3 protein in the breast cancer tissues was higher in patients carrying the rs10053538 GT+TT genotype than those with GG genotype (P = 0.012). However, we failed to find any difference between BC patients and controls in any rs1036199 genetic model. These findings suggested that rs10053538 in TIM-3 might increase susceptibility to BC and promote the progression of BC in Chinese women." @default.
• W2397956340 created "2016-06-24" @default.
• W2397956340 creator A5004022391 @default.
• W2397956340 creator A5008513324 @default.
• W2397956340 creator A5025550930 @default.
• W2397956340 creator A5030171451 @default.
• W2397956340 creator A5036726873 @default.
• W2397956340 creator A5045570568 @default.
• W2397956340 creator A5047447008 @default.
• W2397956340 creator A5052267876 @default.
• W2397956340 creator A5073955179 @default.
• W2397956340 creator A5081012496 @default.
• W2397956340 creator A5085095982 @default.
• W2397956340 date "2016-05-27" @default.
• W2397956340 modified "2023-10-14" @default.
• W2397956340 title "Polymorphisms in <i>TIM-3</i> and breast cancer susceptibility in Chinese women: A case-control study" @default.
• W2397956340 cites W1480254377 @default.
• W2397956340 cites W1643523773 @default.
• W2397956340 cites W1760083413 @default.
• W2397956340 cites W1833542149 @default.
• W2397956340 cites W1873877219 @default.
• W2397956340 cites W1892403210 @default.
• W2397956340 cites W1911405084 @default.
• W2397956340 cites W1926380205 @default.
• W2397956340 cites W1962920088 @default.
• W2397956340 cites W1966073503 @default.
• W2397956340 cites W1967222937 @default.
• W2397956340 cites W1968848781 @default.
• W2397956340 cites W1976696028 @default.
• W2397956340 cites W1979842508 @default.
• W2397956340 cites W1980200253 @default.
• W2397956340 cites W1989108484 @default.
• W2397956340 cites W1998132569 @default.
• W2397956340 cites W2003737490 @default.
• W2397956340 cites W2042098732 @default.
• W2397956340 cites W2070631889 @default.
• W2397956340 cites W2073258900 @default.
• W2397956340 cites W2092107004 @default.
• W2397956340 cites W2100802093 @default.
• W2397956340 cites W2105344065 @default.
• W2397956340 cites W2108158604 @default.
• W2397956340 cites W2114381434 @default.
• W2397956340 cites W2122730216 @default.
• W2397956340 cites W2144297538 @default.
• W2397956340 cites W2146114241 @default.
• W2397956340 cites W2148287035 @default.
• W2397956340 cites W2167717479 @default.
• W2397956340 cites W2168489055 @default.
• W2397956340 cites W2172223853 @default.
• W2397956340 cites W2194181744 @default.
• W2397956340 cites W2203541757 @default.
• W2397956340 cites W2286284605 @default.
• W2397956340 cites W2319984496 @default.
• W2397956340 cites W2406064698 @default.
• W2397956340 cites W2414093793 @default.
• W2397956340 cites W2429473595 @default.
• W2397956340 cites W4253611021 @default.
• W2397956340 doi "https://doi.org/10.18632/oncotarget.9665" @default.
• W2397956340 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5190054" @default.
• W2397956340 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27248321" @default.
• W2397956340 hasPublicationYear "2016" @default.
• W2397956340 type Work @default.
• W2397956340 sameAs 2397956340 @default.
• W2397956340 citedByCount "22" @default.
• W2397956340 countsByYear W23979563402016 @default.
• W2397956340 countsByYear W23979563402017 @default.
• W2397956340 countsByYear W23979563402018 @default.
• W2397956340 countsByYear W23979563402019 @default.
• W2397956340 countsByYear W23979563402020 @default.
• W2397956340 countsByYear W23979563402021 @default.
• W2397956340 countsByYear W23979563402022 @default.
• W2397956340 countsByYear W23979563402023 @default.
• W2397956340 crossrefType "journal-article" @default.
• W2397956340 hasAuthorship W2397956340A5004022391 @default.
• W2397956340 hasAuthorship W2397956340A5008513324 @default.
• W2397956340 hasAuthorship W2397956340A5025550930 @default.
• W2397956340 hasAuthorship W2397956340A5030171451 @default.
• W2397956340 hasAuthorship W2397956340A5036726873 @default.
• W2397956340 hasAuthorship W2397956340A5045570568 @default.
• W2397956340 hasAuthorship W2397956340A5047447008 @default.
• W2397956340 hasAuthorship W2397956340A5052267876 @default.
• W2397956340 hasAuthorship W2397956340A5073955179 @default.
• W2397956340 hasAuthorship W2397956340A5081012496 @default.
• W2397956340 hasAuthorship W2397956340A5085095982 @default.
• W2397956340 hasBestOaLocation W23979563401 @default.
• W2397956340 hasConcept C104317684 @default.
• W2397956340 hasConcept C121608353 @default.
• W2397956340 hasConcept C126322002 @default.
• W2397956340 hasConcept C135763542 @default.
• W2397956340 hasConcept C143998085 @default.
• W2397956340 hasConcept C146304588 @default.
• W2397956340 hasConcept C530470458 @default.
• W2397956340 hasConcept C54355233 @default.
• W2397956340 hasConcept C556039675 @default.
• W2397956340 hasConcept C71924100 @default.
• W2397956340 hasConcept C86803240 @default.
• W2397956340 hasConceptScore W2397956340C104317684 @default.
• W2397956340 hasConceptScore W2397956340C121608353 @default.

• next